Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
about
In Vivo Confocal Microscopy of the Human Cornea in the Assessment of Peripheral Neuropathy and Systemic DiseasesEffects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathyCutaneous neuropathy in Parkinson's disease: a window into brain pathology.New treatments for the motor symptoms of Parkinson's disease.Self-Injurious Behavior Secondary to Cytomegalovirus-Induced Neuropathy in an SIV-Infected Rhesus Macaque (Macaca mulatta)Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experienceCurrent Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Pathophysiology of Small-Fiber Sensory System in Parkinson's Disease: Skin Innervation and Contact Heat Evoked Potential.Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.Novel formulations and modes of delivery of levodopa.Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.Carbidopa levodopa enteral suspension.Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.Novel Levodopa Formulations for Parkinson's Disease.Intrajejunal levodopa infusion therapy for Parkinson's disease: practical and pragmatic tips for successful maintenance of therapy.Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation.Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment.Infusion-rate-dependent Acute Neuropathic Pain with Duopa in a Patient with Parkinson's Disease and Pre-existing Neuropathy
P2860
Q26771756-4F34A123-D4B6-43D3-B243-F2F5DED4E739Q33695388-7D525356-747C-4571-9B74-76B6EE83647EQ33764504-C835E23B-B2A4-4A67-B457-E266E94830D8Q34443682-CE8CEE92-04C4-47E1-884E-6EFB5D917DB8Q35798495-6243269D-A714-4EDC-9C9F-DA27A824AFFBQ36105287-17761BBA-D5C9-4B44-908A-561064C60BB6Q36724032-E3D7BBF0-01F6-488F-B197-95FD2FC5F3BAQ36925905-F12327A5-2ED4-424A-BCB6-8DAC7C77C605Q37207179-134B5AAC-F03D-4CA1-8D18-53804990E345Q38244310-957B099C-ABD3-4B9A-867E-3F906ABD10D7Q38283415-E83C462C-949A-48A7-BAC7-A9C2F0BD9DEBQ38316108-19F15D59-C1F6-43B5-A505-9196017BC423Q38478999-101FBB03-2876-47E6-90C8-E37153B44B2FQ38643494-CAE3B384-824A-48BD-B983-5C721FDE73C7Q38649251-5B1E3BB7-104A-4808-B806-834BF476FB6CQ38823793-C4E954BB-9325-4E37-BC06-56497B7DAB04Q38981419-6C5CA929-EBA5-46D8-93B6-3663EADEB78DQ39240060-14468329-35E2-4FB4-95C9-0184CB21C9FEQ48233156-E6EEA55C-5F9E-45AA-9236-9F512C0B4BFAQ48287261-1B3A2833-73F6-42AA-8B69-8FF3915E632BQ53661046-1C96BEEF-7E93-4BD9-BC63-384C8C177F87Q57138445-C0CEBE23-0132-4101-9045-2A7E2ED3CEF4
P2860
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prevalence and features of per ...... ifferent therapeutic regimens.
@en
Prevalence and features of per ...... ifferent therapeutic regimens.
@nl
type
label
Prevalence and features of per ...... ifferent therapeutic regimens.
@en
Prevalence and features of per ...... ifferent therapeutic regimens.
@nl
prefLabel
Prevalence and features of per ...... ifferent therapeutic regimens.
@en
Prevalence and features of per ...... ifferent therapeutic regimens.
@nl
P2093
P50
P1476
Prevalence and features of per ...... different therapeutic regimens
@en
P2093
C Pacchetti
G D Oggioni
G Riboldazzi
M Coletti Moja
M Dal Fante
M Lacerenza
P356
10.1016/J.PARKRELDIS.2013.09.007
P577
2013-09-25T00:00:00Z